SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Saamya Biotech India informs about board meeting

06 Mar 2017 Evaluate

Saamya Biotech India has informed that a meeting of the Board of Directors of the Company will be held on March 09, 2017, to consider and transact the appointment of Statutory Auditor to fill casual vacancy caused by the resignation of Statutory Auditors, and to consider and approve calling for Notice of Extra-Ordinary General Meeting / Postal Ballot of members.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×